Free Trial

Trellus Health (TRLS) Competitors

GBX 0.65 0.00 (0.00%)
As of 07/4/2025

TRLS vs. FDBK, IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, and COG

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), and Cambridge Cognition (COG). These companies are all part of the "health information services" industry.

Trellus Health vs. Its Competitors

Trellus Health (LON:TRLS) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

Trellus Health has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500.

Trellus Health has higher earnings, but lower revenue than Feedback. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£65.83K19.09-£7.98M-£3.45-0.19
Feedback£3.88M1.64-£10.84M-£24.74-0.59

19.3% of Trellus Health shares are owned by institutional investors. Comparatively, 53.2% of Feedback shares are owned by institutional investors. 49.7% of Trellus Health shares are owned by insiders. Comparatively, 10.8% of Feedback shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Feedback has a net margin of -279.16% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-12,114.55% -37.95% -22.76%
Feedback -279.16%-39.71%-22.99%

In the previous week, Feedback had 1 more articles in the media than Trellus Health. MarketBeat recorded 1 mentions for Feedback and 0 mentions for Trellus Health. Feedback's average media sentiment score of 1.40 beat Trellus Health's score of 0.00 indicating that Feedback is being referred to more favorably in the news media.

Company Overall Sentiment
Trellus Health Neutral
Feedback Positive

Summary

Trellus Health beats Feedback on 7 of the 13 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£1.26M£214.35M£5.56B£2.96B
Dividend YieldN/A6.68%5.24%5.02%
P/E Ratio-0.19369.5827.64147.88
Price / Sales19.09223.50416.55258,917.23
Price / Cash0.7647.1436.8927.97
Price / Book0.075.158.034.61
Net Income-£7.98M-£15.55M£3.18B£5.90B
7 Day Performance-18.75%-0.71%2.93%1.04%
1 Month Performance-27.86%-0.24%1.72%4.36%
1 Year PerformanceN/A11.40%34.39%82.36%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 0.65
flat
N/A-60.6%£1.26M£65.83K-0.1931
FDBK
Feedback
N/AGBX 14.10
-1.1%
N/A-78.8%£6.18M£3.88M-0.5724
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-27.3%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270News Coverage
Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
N/AGBX 2,090
-0.5%
GBX 2,800
+34.0%
-5.9%£898.00M£230.77M77.22734Gap Up
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
N/AGBX 187
+0.5%
GBX 456.67
+144.2%
-37.3%£68.63M£50.72M17.57478
RENX
Renalytix
N/AGBX 7.20
-0.7%
N/A-32.7%£29.85M£9.22M-0.34102
COG
Cambridge Cognition
N/AGBX 31.15
-7.0%
N/A-14.5%£13.04M£15.64M-8.2880Positive News
High Trading Volume

Related Companies and Tools


This page (LON:TRLS) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners